Dosage determination of ultrasmall particles of iron oxide for the delineation of microvasculature in the wistar rat brain

Investigative Radiology

Volumn 40, Issue 10, 2005, Pages 655-660

  Yang, Ming ^a   Christoforidis, Gregory A ^a,b   Figueredo, Tatiana ^a   Heverhagen, Johannes T ^a   Abduljalil, Amir ^a   Knopp, Michael V ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Brain; Magnetic resonance imaging; Microvasculature; USPIO

Indexed keywords

CONTRAST MEDIUM; SHU 555C; SUPRAVIST; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; BRAIN BLOOD VESSEL; BRAIN CORTEX; IMAGE ANALYSIS; MICROVASCULATURE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO;

EID: 25644433659     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000178432.22377.6c     Document Type: Article

References (31)

1. Chambon C, Clement O, Le Blanche A, et al. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging. 1993;11:509-519.
2. Schmitz SA, Albrecht T, Wolf KJ. MR angiography with superparamagnetic iron oxide: feasibility study. Radiology. 1999;213:603-607.
3. Stillman AE. New contrast agents for cardiovascular MRI and MRA. Int J Cardiovasc Imaging. 2001;17:471-472.
4. Saeed M, Wendland MF, Higgins CB. Blood pool MR contrast agents for cardiovascular imaging. J Magn Reson Imaging. 2000;12:890-898.
5. Schnorr J, Wagner S, Abramjuk C, et al. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs. Invest Radiol. 2004;39:546-553.
6. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superpara-magnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology. 1990;175:489-493.
7. Allkemper T, Bremer C, Matuszewski L, et al. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology. 2002; 223:432-438.
8. Bjerner T, Johansson L, Wikstrom G, et al. In and ex vivo MR evaluation of acute myocardial ischemia in pigs by determining R1 in steady state after the administration of the intravascular contrast agent NC100150 injection. Invest Radiol 2004;39:479-486.
9. Christoforidis GA, Bourekas EC, Baujan M, et al. High resolution MRI of the deep brain vascular anatomy at 8 Tesla: susceptibility-based enhancement of the venous structures. J Comput Assist Tomogr. 1999; 23:857-866.
10. Abduljalil AM, Schmalbrock P, Novak V, Chakeres DW. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging. 2003;18:284-290.
11. Christoforidis GA, Grecula JC, Newton HB, et al. Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. AJNR Am J Neuroradiol. 2002;23:1553-1556.
12. Christoforidis GA, Kangarlu A, Abduljalil AM, et al. Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR Am J Neuroradiol. 2004;25:756-760.
13. Dousset V, Gomez C, Perry KG, et al. Dose and scanning delay using USPIO for central nervous system macrophage imaging. Magma. 1999; 8:185-189.
14. Kaim AH, Wischer T, O'Reilly T, et al. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology. 2002;225:808-814.
15. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology. 1990;175:494-498.
16. Rausch M, Sauter A, Frohlich J, et al. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med. 2001;46:1018-1022.
17. Bjerner T, Wikstrom G, Johansson L, et al. High in-plane resolution T2-weighted magnetic resonance imaging of acute myocardial ischemia in pigs using the intravascular contrast agent NC100150 injection. Invest Radiol. 2004;39:470-478.
18. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257.
19. Abduljalil AM, Kangarlu A, Zhang X, et al. Acquisition of human multislice MR images at 8 Tesla. J Comput Assist Tomogr. 1999;23: 335-340.
20. Abduljalil AM, Robitaille PM. Macroscopic susceptibility in ultra high field MRI. J Comput Assist Tomogr. 1999;23:832-841.
21. Kangarlu A, Abduljalil AM, Robitaille PM. T1- and T2-weighted imaging at 8 Tesla. J Comput Assist Tomogr. 1999;23:875-878.
22. Laghi A, Paolantonio P, Panebianco V, et al. Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms. Invest Radiol. 2004;39: 666-670.
23. Mack MG, Balzer JO, Straub R, et al. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology. 2002;222:239-244.
24. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415-422.
25. Saini S, Edelman RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR Am J Roentgenol. 1995;164:1147-1152.
26. Taupitz M, Schnorr J, Abramjuk C, et al. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging. 2000;12;905-911.
27. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52:612-618.
28. Dashner RA, Kangarlu A, Clark DL, et al. Limits of 8-Tesla magnetic resonance imaging spatial resolution of the deoxygenated cerebral microvasculature. J Magn Reson Imaging. 2004;19:303-307.
29. Dashner RA, Chakeres DW, Kangarlu A, et al. MR imaging visualization of the cerebral microvasculature: a comparison of live and post-mortem studies at 8 T. Am J Neuroradiol. 2003;24:1738-1739.
30. Raynal I, Prigent P, Peyramaure S, et al. Macrophage endocytosis of superpara-magnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol. 2004;39:56-63.
31. Taupitz M, Wagner S, Schnorr J, et al. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol. 2004;39:394-405.